ALMR
Alamar Biosciences, Inc. Common StockNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.39B
P/E Ratio
—
EPS
$-0.65
Beta
—
52W High
$27.20
52W Low
$17.00
50-Day MA
$23.28
200-Day MA
$23.28
Dividend Yield
—
Profit Margin
-49.90%
Forward P/E
—
PEG Ratio
—
About Alamar Biosciences, Inc. Common Stock
Alamar Biosciences, Inc. is a leading biotechnology company focused on developing innovative diagnostic solutions for infectious diseases, leveraging its proprietary technologies to enhance patient care and treatment outcomes. The company's advanced platform offers rapid and accurate testing capabilities aimed at significantly improving clinical decision-making processes. With a strong commitment to research and development, Alamar is poised to address unmet medical needs within the healthcare sector, presenting an attractive opportunity for institutional investors looking to capitalize on the growth potential in the diagnostics market.
Fundamentals
| Revenue (TTM) | $87.16M |
| Gross Profit (TTM) | $49.77M |
| EBITDA | $-32.09M |
| Operating Margin | -47.40% |
| Return on Equity | -33.60% |
| Return on Assets | -13.50% |
| Revenue/Share (TTM) | $7.39 |
| Book Value | $-2.57 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 15.95 |
| EV/Revenue | 16.42 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 98.90% |
| Shares Outstanding | $69.31M |
| Float | $38.15M |
| % Insiders | 26.68% |
| % Institutions | 28.31% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026